老年疑难危重病例解析
上QQ阅读APP看书,第一时间看更新

参考文献

1.Rapezzi C,Merlini G,Quarta CC,et al. Systemic cardiac amyloidoses:disease profiles and clinical courses of the 3 main types[J]. Circulation,2009,120(13):1203-1212.
2.Falk RH. Diagnosis and management of the cardiac amyloidoses[J]. Circulation,2005,112(13):2047-2060.
3.Quarta CC,Solomon SD,Uraizee I,et al. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis[J]. Circulation,2014,129(18):1840-1849.
4.Fine NM,Arruda-Olson AM,Dispenzieri A,et al. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis[J]. Am J Cardiol,2014,113(10):1723-1727.
5.Aljaroudi WA,Desai MY,Tang WH,et al. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis:state of the art review and focus on emerging nuclear techniques[J]. J NuclCardiol,2014,21(2):271-283.
6.Maleszewski J J. Cardiac amyloidosis:pathology,nomenclature,and typing [J]. Cardiovascular pathology:the official journal of the Society for Cardiovascular Pathology,2015,24(6):343-350.
7.Mohammed S F,Mirzoyev S A,Edwards W D,et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction [J]. JACC Heart failure,2014,2(2):113-122.
8.Tsai SB1,Seldin DC,Wu H,et al. Myocardial infarction with “clean coronaries” caused by amyloid light-chain AL amyloidosis:a case report and literature review[J]. Amyloid,2011,18(3):160-164.
9.Dorbala S,Vangala D,Bruyere J Jr,.Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis[J].JACC Heart Fail,2014,2(4):358-367.
10.Feng D,Edwards WD,Oh JK,et al.Intracardiac thrombosis and embolism in patients with cardiac amyloidosis[J].Circulation,2007,116(21):2420-2426.
11.Feng D,Syed IS,Martinez M,et al. Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis[J]. Circulation,2009,119(18):2490-2497.
12.Guan J,Mishra S,Qiu Y,et al. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity[J]. EMBO Mol Med,2014,6(11):1493-1507.
13.Migrino RQ1,Truran S,Gutterman DD,et al. Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins[J]. Am J Physiol Heart Circ Physiol,2011,301(6):H2305-2312.